Figure 4
Figure 4. In vitro–generated BCR/ABL-expressing DCs have a low maturation status. (A-D) DCs were generated in vitro from BCR/ABL-GFP or empty vector GFP–transduced H8 bone marrow cells. Immature (A), LPS-matured (B), and αCD40-maturated (C) BCR/ABL-expressing and control DCs were analyzed for MHC class IIhigh molecules, CD86, CD80, CD83, and CD70 expression by flow cytometry. Dot plots are gated on GFP-expressing cells. Numbers indicate the percentage of CD11c+ DCs expressing the stained molecule. (D) Summary of data in panel B of 3 independent experiments is shown as percentage (mean ± SEM) of MHC class IIhigh, CD86+, CD80+, CD83+, or CD70+ cells within total GFP+CD11c+ cells: (■) represents BCR/ABL-expressing DCs; (□), empty GFP vector–transduced control DCs, LPS-matured; ns indicates not significant.

In vitro–generated BCR/ABL-expressing DCs have a low maturation status. (A-D) DCs were generated in vitro from BCR/ABL-GFP or empty vector GFP–transduced H8 bone marrow cells. Immature (A), LPS-matured (B), and αCD40-maturated (C) BCR/ABL-expressing and control DCs were analyzed for MHC class IIhigh molecules, CD86, CD80, CD83, and CD70 expression by flow cytometry. Dot plots are gated on GFP-expressing cells. Numbers indicate the percentage of CD11c+ DCs expressing the stained molecule. (D) Summary of data in panel B of 3 independent experiments is shown as percentage (mean ± SEM) of MHC class IIhigh, CD86+, CD80+, CD83+, or CD70+ cells within total GFP+CD11c+ cells: (■) represents BCR/ABL-expressing DCs; (□), empty GFP vector–transduced control DCs, LPS-matured; ns indicates not significant.

Close Modal

or Create an Account

Close Modal
Close Modal